Published in Respiration on July 16, 2013
Measurement of intraindividual airway tone heterogeneity and its importance in asthma. J Appl Physiol (1985) (2016) 0.75
Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med (1999) 29.97
Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest (1995) 2.47
Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest (1995) 2.36
S-nitrosothiol signaling in respiratory biology. Am J Respir Crit Care Med (2006) 1.84
Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 1.68
Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharmacol (1992) 1.67
Potent bronchoprotective effect of deep inspiration and its absence in asthma. J Appl Physiol (1985) (2000) 1.56
The lack of the bronchoprotective and not the bronchodilatory ability of deep inspiration is associated with airway hyperresponsiveness. Am J Respir Crit Care Med (2001) 1.38
Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J Exp Med (1999) 1.38
High-resolution computed tomographic evaluation of airway distensibility and the effects of lung inflation on airway caliber in healthy subjects and individuals with asthma. Am J Respir Crit Care Med (2001) 1.37
Frozen objects: small airways, big breaths, and asthma. J Allergy Clin Immunol (2000) 1.30
Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation. Prog Neurobiol (1998) 1.23
Deep inspiration-induced bronchoprotection is stronger than bronchodilation. Am J Respir Crit Care Med (2000) 1.21
Airway nitric oxide diffusion in asthma: Role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med (2000) 1.19
Selected contribution: plasticity of airway smooth muscle stiffness and extensibility: role of length-adaptive mechanisms. J Appl Physiol (1985) (2001) 1.17
Mechanism of stretch-activated excitatory and inhibitory responses in the lower esophageal sphincter. Am J Physiol Gastrointest Liver Physiol (2009) 1.14
Nitric oxide signaling in the cardiovascular system: implications for heart failure. Curr Opin Cardiol (2006) 1.06
Nitric oxide induces airway smooth muscle cell relaxation by decreasing the frequency of agonist-induced Ca2+ oscillations. J Gen Physiol (2010) 1.05
Role of nitric oxide on eosinophilic lung inflammation in allergic mice. Am J Respir Cell Mol Biol (1997) 1.04
Bronchoprotective and bronchodilatory effects of deep inspiration in rabbits subjected to bronchial challenge. J Appl Physiol (1985) (2001) 1.01
Bronchodilation response to deep inspirations in asthma is dependent on airway distensibility and air trapping. J Appl Physiol (1985) (2010) 1.00
Decreased pulmonary and tracheal smooth muscle expression and activity of type 1 nitric oxide synthase (nNOS) after ovalbumin immunization and multiple aerosol challenge in guinea pigs. Am J Respir Crit Care Med (2001) 0.98
Isozyme-selective cyclic nucleotide phosphodiesterase inhibitors: biochemistry, pharmacology and therapeutic potential in asthma. Prog Drug Res (1993) 0.97
Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in animal models of airways disease. Am J Respir Crit Care Med (2003) 0.90
Nitric oxide and bronchial hyperresponsiveness. Arch Int Pharmacodyn Ther (1995) 0.90
Duration of deep inspiration and subsequent airway constriction in vivo. J Asthma (2003) 0.90
Airways hyperresponsiveness and the effects of lung inflation. Int Arch Allergy Immunol (2001) 0.89
Airway response to deep inspiration: role of inflation pressure. J Appl Physiol (1985) (2001) 0.89
Airway response to deep inspiration: role of nitric oxide. Eur Respir J (2003) 0.89
Inhibition by L-NG-nitro-L-arginine of nonadrenergic-noncholinergic-mediated relaxations of human isolated central and peripheral airway. Am Rev Respir Dis (1992) 0.89
Nitric oxide synthase in neurons and nerve fibers of lower airways and in vagal sensory ganglia of man. Correlation with neuropeptides. Am J Respir Crit Care Med (1996) 0.89
Inhaled corticosteroids and the beneficial effect of deep inspiration in asthma. Am J Respir Crit Care Med (2005) 0.88
The effect of selective phosphodiesterase inhibitors, alone and in combination, on a murine model of allergic asthma. Respir Res (2004) 0.85
Nitric oxide mediates stretch-induced Ca2+ release via activation of phosphatidylinositol 3-kinase-Akt pathway in smooth muscle. PLoS One (2008) 0.84
Calcium sensors as new therapeutic targets for airway hyperresponsiveness and asthma. FASEB J (2001) 0.83
The role of lung inflation in airway hyperresponsiveness and in asthma. Curr Allergy Asthma Rep (2004) 0.82
Reduced airway responsiveness in nonelite runners. Med Sci Sports Exerc (2005) 0.81
Sildenafil decreases rat tracheal hyperresponsiveness to carbachol and changes canonical transient receptor potential gene expression after antigen challenge. Braz J Med Biol Res (2011) 0.79
Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci (2006) 6.53
Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med (2011) 5.61
Mutant dynactin in motor neuron disease. Nat Genet (2003) 5.28
Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet (2009) 4.38
Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci (2010) 4.25
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet (2006) 3.88
dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science (2012) 3.72
Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet (2011) 3.68
Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol (2010) 3.61
Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol (2004) 3.49
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12
XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev (2009) 3.03
Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem (2003) 3.00
Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet (2010) 2.75
Axonal transport defects in neurodegenerative diseases. J Neurosci (2009) 2.74
EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med (2012) 2.65
Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron (2004) 2.53
Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell (2010) 2.42
The structural basis of airways hyperresponsiveness in asthma. J Appl Physiol (1985) (2006) 2.40
Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J Biol Chem (2002) 2.34
Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum Mol Genet (2004) 2.32
T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc Natl Acad Sci U S A (2008) 2.26
Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet (2009) 2.22
Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. J Clin Invest (2011) 2.08
Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature (2012) 2.08
Omalizumab-induced reductions in mast cell Fce psilon RI expression and function. J Allergy Clin Immunol (2004) 2.06
Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2009) 2.03
Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg (2004) 2.01
A yeast model of FUS/TLS-dependent cytotoxicity. PLoS Biol (2011) 1.95
Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem (2010) 1.93
The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort. AIDS (2013) 1.92
Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. J Neurochem (2005) 1.91
Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem (2005) 1.91
Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci Transl Med (2011) 1.87
Dysferlin in membrane trafficking and patch repair. Traffic (2007) 1.82
The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder. Eur J Hum Genet (2012) 1.71
Familial amyotrophic lateral sclerosis-associated mutations decrease the thermal stability of distinctly metallated species of human copper/zinc superoxide dismutase. J Biol Chem (2002) 1.69
Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy (2009) 1.65
A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q. Am J Hum Genet (2001) 1.65
Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord (2003) 1.65
Bronchodilatory effect of deep inspiration is absent in subjects with mild COPD. Chest (2004) 1.62
Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. Am J Hum Genet (2003) 1.56
Negative pressure pulmonary edema following bronchospasm. Chest (2011) 1.55
Amyotrophic lateral sclerosis: Problems and prospects. Ann Neurol (2013) 1.53
Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities. Proc Natl Acad Sci U S A (2009) 1.49
Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration. Hum Mol Genet (2008) 1.46
Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol (2011) 1.45
Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1. J Neurosci (2009) 1.44
Prenatal maternal stress and cord blood innate and adaptive cytokine responses in an inner-city cohort. Am J Respir Crit Care Med (2010) 1.43
An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis. Biochemistry (2004) 1.43
Effects of exercise training on airway responsiveness and airway cells in healthy subjects. J Appl Physiol (1985) (2010) 1.43
Lung Density Changes With Growth and Inflation. Chest (2015) 1.42
Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J Neurosci (2008) 1.39
Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation. Proc Natl Acad Sci U S A (2005) 1.36
Case records of the Massachusetts General Hospital. Case 22-2006--a 77-year-old man with a rapidly progressive gait disorder. N Engl J Med (2006) 1.36
Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol (2006) 1.33
A graphical assessment of p-values from sliding window haplotype tests of association to identify asthma susceptibility loci on chromosome 11q. BMC Genet (2006) 1.33
Emerging mechanisms of molecular pathology in ALS. J Clin Invest (2015) 1.32
Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions. Brain Pathol (2010) 1.31
Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. Hum Mol Genet (2005) 1.31
ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2. Hum Mol Genet (2010) 1.31
Compositional maps of Saturn's moon Phoebe from imaging spectroscopy. Nature (2005) 1.31
Metabolomic analysis and signatures in motor neuron disease. Metabolomics (2005) 1.31
Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G⁹³A transgenic ALS mice. J Neurosci (2011) 1.29
Mutant SPTLC1 dominantly inhibits serine palmitoyltransferase activity in vivo and confers an age-dependent neuropathy. Hum Mol Genet (2005) 1.29
Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy Clin Immunol (2010) 1.27
Parental characteristics, somatic fetal growth, and season of birth influence innate and adaptive cord blood cytokine responses. J Allergy Clin Immunol (2009) 1.23
Asthma outcomes workshop: overview. J Allergy Clin Immunol (2012) 1.22
Caspase-3 cleaves and inactivates the glutamate transporter EAAT2. J Biol Chem (2006) 1.21
Genetic variants of the T-cell immunoglobulin mucin 1 but not the T-cell immunoglobulin mucin 3 gene are associated with asthma in an African American population. J Allergy Clin Immunol (2005) 1.20
Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ann Neurol (2010) 1.20
The role of copy number variation in susceptibility to amyotrophic lateral sclerosis: genome-wide association study and comparison with published loci. PLoS One (2009) 1.19
Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax (2011) 1.16
The role of the nervous system in rhinitis. J Allergy Clin Immunol (2006) 1.15
RNA metabolism and the pathogenesis of motor neuron diseases. Trends Neurosci (2010) 1.15
Hereditary sensory neuropathy type 1 mutations confer dominant negative effects on serine palmitoyltransferase, critical for sphingolipid synthesis. J Clin Invest (2002) 1.14
Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol Genomics (2004) 1.14
Decreased pulmonary vascular permeability in aquaporin-1-null humans. Proc Natl Acad Sci U S A (2002) 1.13
Clinical practice. Allergic rhinitis. N Engl J Med (2015) 1.11
Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability. Hum Mol Genet (2004) 1.11
Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis. Sci Transl Med (2012) 1.10
Homologous recombination mediates functional recovery of dysferlin deficiency following AAV5 gene transfer. PLoS One (2012) 1.10
Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy. Am J Hum Genet (2011) 1.09
Commentaries on Viewpoint: Airway smooth muscle and airway hyperresponsiveness in human asthma: have we chased the wrong horse? J Appl Physiol (1985) (2014) 1.08
Local allergic rhinitis: concept, pathophysiology, and management. J Allergy Clin Immunol (2012) 1.08
Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler (2006) 1.08
Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2014) 1.08
Health care costs of allergic rhinitis-associated conditions vary with allergy season. Ann Allergy Asthma Immunol (2002) 1.07
RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells. Proc Natl Acad Sci U S A (2004) 1.07
Objective monitoring of nasal patency and nasal physiology in rhinitis. J Allergy Clin Immunol (2005) 1.06
Phase 2 study of sodium phenylbutyrate in ALS. Amyotroph Lateral Scler (2009) 1.05
Polymorphisms in the myosin light chain kinase gene that confer risk of severe sepsis are associated with a lower risk of asthma. J Allergy Clin Immunol (2007) 1.05
Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis. Muscle Nerve (2008) 1.04
Motor unit number estimation predicts disease onset and survival in a transgenic mouse model of amyotrophic lateral sclerosis. Muscle Nerve (2006) 1.04
Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes. J Immunol Methods (2012) 1.04
Targeted mutation of mouse skeletal muscle sodium channel produces myotonia and potassium-sensitive weakness. J Clin Invest (2008) 1.03
Pathophysiology of allergic and nonallergic rhinitis. Proc Am Thorac Soc (2011) 1.03
Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis. Hum Mol Genet (2013) 1.02
The impact of age on prevalence of positive skin prick tests and specific IgE tests. Respir Med (2011) 1.02
A common haplotype within the PON1 promoter region is associated with sporadic ALS. Amyotroph Lateral Scler (2008) 1.02